A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity

Journal of Clinical Gastroenterology

Volumn 42, Issue 1, 2008, Pages 48-53

  Lopasso, Fabio P ^a   Sakai, Paulo ^a   Gazi, Bashir M ^b   Artifon, Everson L A ^a   Kfouri, Christiane ^b   Souza, Jussara P B ^b   Kumar, Atul ^c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ANA COSTA   (Brazil)

^c STONY BROOK UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Gastric balloon; Obesity; Weight loss

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; IMPLANTATION; MALE; MEDICAL INSTRUMENTATION; OBESITY; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; SAFETY; STATIONARY ANTRAL BALLOON; THERAPY EFFECT; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; BRAZIL; CALORIC RESTRICTION; FEMALE; GASTRIC BALLOON; HUMANS; MALE; OBESITY; PATIENT COMPLIANCE; PILOT PROJECTS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 37549067337     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000247992.89215.88     Document Type: Article

References (27)

1. Geliebter A, Melton PM, Gage D, et al. Gastric balloon to treat obesity: a double balloon study in nondieting subjects. Am J Clin Nutr. 1990;51:584-588.
2. Jones KL, Doran SM, Hveem K, et al. Relation between postprandial satiation and antral area in normal subjects. Am J Clin Nutr. 1997;66:127-132.
3. Hausken T, Berstad A. Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride. Scand J Gastroenterol. 1992;27:427-432.
4. Geliebter A. Gastric distention and gastric capacity in relation to food intake in humans. Physiol Behav. 1988;44:665-668.
5. Doldi SB, Micheletto G, Di Prisco F, et al. Intragastric balloon in obese patients. Obes Surg. 2000;10:578-581.
6. Bonassi U, Lella F, Bagnol F, et al. Non-surgical treatment of morbid obesity: prospective evaluation after the placement of intragastric ballon. Gastroenterology. 2000;118:A770.
7. Genco A, Cipriano M, Bacci V, et al. Bioenterics intragastric balloon (BIB); a short term, double-blind, randomized, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129-133.
8. Mathus Vliegen EMH, Tytgat GNJ, Veldehuyzen-Offermans EAML. Intragastric balloon in the treatment of super-morbid obesity. Gastroenterology. 1990;99:362-369.
9. Mathus-Vliegen EMH, Tytgat CNJ. Intragastric balloon for morbid obesity: result, patient's tolerance and balloon life span. Br J Surg. 1990;77:76-79.
10. Gemayel N, Laine L, Cohen H, et al. A prospective controlled trial of the Garren gastric bubble with or without 600-calorie diet on weight loss and gastric emptying (abstract). Gut. 1987;28:1412.
11. Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510-516.
12. Roman S, Napoléon B, Mion F, et al. Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficiency. Obes Surg. 2004;14:539-544.
13. Hodson RM, Zacharoulis D, Goutzamani E, et al. Management of obesity with the new intragastric balloon. Obes Surg. 2004;11:327-329.
14. Totte E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric ballon. Obes Surg. 2001;11:519-517.
15. Loffredo A, Cappuccio M, De Luca M, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg. 2001;11:330-333.
16. Stoltenberg PH, Piziak VK, Dietscher JE. Intragastric balloon therapy of obesity: a randomized double-blind trial (abstract). Gastroenterology. 1987;92:1506.
17. Durrans D, Taylor TV, Pullan BR. Intragastric balloons. Short term solution to a long term problem. J R Coll Edinb. 1985;30:369-371.
18. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev. 1987;8:256-287.
19. Bergmann JF, Chassany O, Petit A, et al. Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut. 1992;33:1042-1043.
20. Doldi SB, Micheletto G, Perrini MN, et al. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepatogastroenterology. 2004;51:294-297.
21. Benjamin SB, Maher KA, Cattau EL, et al. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity. Gastroenterology. 1988;95:581-588.
22. Evans JD, Scott MH. Intragasrtic balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245-1248.
23. Giardello C, Cristiano S, Carbone MR, et al. Gastric perforation in an obese patient with an intragastric balloon, following previous fundoplication. Obes Surg. 2003;14:539-544.
24. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15:101-105.
25. Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19-27.
26. Kirby DF, Wade JB, Mills PR, et al. Prospective Observations in Obese Patients Treated with the Garren Bubble. Obesity and the Gastric Balloon, a Comprehensive Workshop, Tarpon Springs. Florida, Santa Ana, CA: American Edwards Laboratories; 1987.
27. Frank BB, Stern WR, Fisher AH. Survey of Gastric Bubble Usage in the United States. Rockville, MD: Fisher; 1987.